# PiB PET Scanning in Speech and Language Based Dementias

> **NCT01623284** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 168 (actual)

## Conditions studied

- PPA
- Primary Progressive Aphasia
- Aphasia
- Non-fluent Aphasia
- Semantic Dementia
- Apraxia of Speech
- Primary Progressive Nonfluent Aphasia
- Progressive Aphasia

## Interventions

- **DRUG:** C-11 PiB
- **DRUG:** F-18 FDG

## Key facts

- **NCT ID:** NCT01623284
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623284, "PiB PET Scanning in Speech and Language Based Dementias". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01623284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
